UnitedHealth Group Incorporated $UNH Shares Sold by Antonelli Financial Advisors LLC

Antonelli Financial Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,230 shares of the healthcare conglomerate’s stock after selling 210 shares during the period. Antonelli Financial Advisors LLC’s holdings in UnitedHealth Group were worth $384,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. NavPoint Financial Inc. increased its position in UnitedHealth Group by 6.4% during the second quarter. NavPoint Financial Inc. now owns 1,293 shares of the healthcare conglomerate’s stock worth $404,000 after purchasing an additional 78 shares during the last quarter. Galvin Gaustad & Stein LLC boosted its stake in UnitedHealth Group by 35.5% during the second quarter. Galvin Gaustad & Stein LLC now owns 78,913 shares of the healthcare conglomerate’s stock worth $24,618,000 after buying an additional 20,688 shares during the period. Cardano Risk Management B.V. boosted its stake in UnitedHealth Group by 2.4% during the second quarter. Cardano Risk Management B.V. now owns 263,367 shares of the healthcare conglomerate’s stock worth $82,163,000 after buying an additional 6,169 shares during the period. Elefante Mark B boosted its stake in UnitedHealth Group by 9.2% during the second quarter. Elefante Mark B now owns 6,441 shares of the healthcare conglomerate’s stock worth $2,009,000 after buying an additional 541 shares during the period. Finally, Commerzbank Aktiengesellschaft FI boosted its stake in UnitedHealth Group by 18.7% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 55,332 shares of the healthcare conglomerate’s stock worth $17,262,000 after buying an additional 8,708 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday. Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday. Truist Financial raised their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Stock Down 0.6%

UNH stock opened at $367.69 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company’s 50 day moving average is $315.87 and its two-hundred day moving average is $351.51. The stock has a market cap of $333.01 billion, a P/E ratio of 15.93, a PEG ratio of 2.39 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.